Valeo S.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:Valeo S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11778
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:自動車
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Valeo S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Valeo S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Valeo S.A. (Valeo or ‘the company’) designs, develops, manufactures, and markets of of components, systems and modules for automotive industry. The company’s products portfolio comprise lighting systems, transmissions, engine cooling equipment, electrical systems, electrical accessories, braking, engine management, switches, security systems, climate control compressors, and modules. It offers its products to aftermarket services supplying original equipment spares and replacement parts to car manufacturers and independent aftermarket. Valeo’s manufacturing and research and development facilities are in various regions such as Europe, North America, South America, Asia and Africa. Valeo is headquartered in Paris, France.

Scope

- Detailed information on Valeo S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Valeo S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Valeo S.A. including a breakdown and examination of key business segments
- Intelligence on Valeo S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Valeo S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Valeo S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Valeo S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Valeo S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Valeo S.A.: Company Overview 9
Valeo S.A.: Overview and Key Facts 9
Valeo S.A.: Overview 9
Valeo S.A.: Key Facts 9
Valeo S.A.: Key Employees 11
Valeo S.A.: Key Employee Biographies 13
Valeo S.A.: Major Products and Services 19
Valeo S.A.: Company History 21
Valeo S.A.: Management Statement 27
Valeo S.A.: Locations and Subsidiaries 29
Valeo S.A.: Key Competitors 31
Valeo S.A.: Company Analysis 32
Valeo S.A.: Business Description 32
Valeo S.A.: SWOT Analysis 34
Valeo S.A.: SWOT Overview 34
Valeo S.A.: Strengths 34
Valeo S.A.: Weaknesses 35
Valeo S.A.: Opportunities 36
Valeo S.A.: Threats 36
Valeo S.A.: Corporate Financial Deals Activity 38
Valeo S.A.: Financial Deals Overview 38
Valeo S.A.: Targets and Partners 40
Valeo S.A.: Top Deals 2014 – 2018YTD* 41
Valeo S.A.: Advisors 42
Valeo S.A.: Top Legal Advisors 42
Valeo S.A.: Top Financial Advisors 42
Valeo S.A.: Mergers and Acquisitions 43
Valeo S.A.: Corporate Venturing 44
Valeo S.A.: Capital Raising 45
Valeo S.A.: Partnership 46
Valeo S.A.: Divestments 47
Valeo S.A.: Private Equity and Ownership 48
Valeo S.A.: Recent Developments 49
Valeo S.A.: News and Events Summary 49
Valeo S.A.: Business Expansion 52
Valeo S.A.: Corporate Governance 52
Valeo S.A.: Financial Deals 53
Valeo S.A.: Financial Performance 53
Valeo S.A.: Regulatory and Legal Events 54
Valeo S.A.: Strategy and Operations 54
Appendix 56
Contact Us 56
Methodology 56
About MarketLine 57

List of Tables
Table 1: Valeo S.A.: Key Facts
Table 2: Valeo S.A.: Key Employees
Table 3: Valeo S.A.: Company History
Table 4: Valeo S.A.: Locations and Subsidiaries
Table 5: Valeo S.A.: Key Competitors
Table 6: Valeo S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Valeo S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Valeo S.A.: M&A Average Deal Size - Value (US$m)
Table 9: Valeo S.A.: Targets and Partners
Table 10: Valeo S.A.: Top Deals 2014 - 2018YTD*
Table 11: Valeo S.A.: Legal Advisor Ranking by Value (US$m)
Table 12: Valeo S.A.: Financial Advisor Ranking by Value (US$m)
Table 13: Valeo S.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Valeo S.A.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Valeo S.A.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Valeo S.A.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Valeo S.A.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Valeo S.A.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Valeo S.A.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Valeo S.A.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Valeo S.A.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: Valeo S.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 23: Valeo S.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 24: Valeo S.A.: News and Events Summary
Table 25: Valeo S.A.: Business Expansion
Table 26: Valeo S.A.: Corporate Governance
Table 27: Valeo S.A.: Financial Deals
Table 28: Valeo S.A.: Financial Performance
Table 29: Valeo S.A.: Regulatory and Legal Events
Table 30: Valeo S.A.: Strategy and Operations

List of Figures
Figure 1: Valeo S.A.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Valeo S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Valeo S.A.: M&A Average Deal Size - Value (US$m)
Figure 4: Valeo S.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Valeo S.A.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Valeo S.A.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: Valeo S.A.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 8: Valeo S.A.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 9: Valeo S.A.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 10: Valeo S.A.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 11: Valeo S.A.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 12: Valeo S.A.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 13: Valeo S.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 14: Valeo S.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Valeo S.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sysmex Corp (6869):企業の製品パイプライン分析2018
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • FAR Ltd (FAR):石油・ガス:M&Aディール及び事業提携情報
    Summary FAR Ltd (FAR), formerly First Australian Resources NL, is an independent oil and gas company that offers acquisition, exploration, production and development of oil and natural gas properties. The company has oilfield appraisal wells and exploration assets in West and East Africa. It operate …
  • METRO Retail Stores Group Inc (MRSGI):企業の財務・戦略的SWOT分析
    METRO Retail Stores Group Inc (MRSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Rakuten, Inc. (4755):企業の財務・戦略的SWOT分析
    Rakuten, Inc. (4755) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • China Life Insurance Co Ltd:企業のM&A・事業提携・投資動向
    China Life Insurance Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Life Insurance Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Dentsu, Inc.:企業の戦略・SWOT・財務分析
    Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ATI Physical Therapy-製薬・医療分野:企業M&A・提携分析
    Summary ATI Physical Therapy (ATI) is a healthcare service provider that offers therapy services. The center offers therapy services such as physical therapy, workers' comp rehab, sports therapy, hand therapy, women's health, specialty therapies, home health and complimentary injury screening servic …
  • Ixia (XXIA):企業の財務・戦略的SWOT分析
    Summary Ixia (Ixia), a subsidiary of Keysight Technologies Inc, is a technology company that offers test architecture solutions and services. The company's products potfolio include visibility, test, cloud, security, performance monitoring, and test hardware products. Its security products comprise …
  • AnaptysBio Inc:企業のM&A・事業提携・投資動向
    AnaptysBio Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AnaptysBio Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • China Construction Bank Corp:企業の戦略・SWOT・財務分析
    China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report Summary China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Robert Half International Inc. (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc. (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Aushon BioSystems Inc-医療機器分野:企業M&A・提携分析
    Summary Aushon BioSystems Inc (Aushon) is a medical device provider that offers biomarker measurement and analysis products. The company provides biomarker therapeutic areas in microarray printing technology. Its products include ciraplex assay, cirascan imaging and cirasoft analysis and cira servic …
  • Societe Generale Private Banking:企業の戦略・SWOT・財務情報
    Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report Summary Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Bando Chemical Industries, Ltd. (5195):企業の財務・戦略的SWOT分析
    Bando Chemical Industries, Ltd. (5195) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Medeon Biodesign Inc (6499):医療機器:M&Aディール及び事業提携情報
    Summary Medeon Biodesign Inc (Medeon Biodesign) is a medical device company that develops patient-centered medical device products that address unmet medical needs. The company’s products include cardiovascular devices and equipment, devices for minimally invasive surgeries, laparoscopic device, hig …
  • Empresas Copec SA (COPEC):企業の財務・戦略的SWOT分析
    Empresas Copec SA (COPEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Jack Henry & Associates, Inc. (JKHY):企業の財務・戦略的SWOT分析
    Jack Henry & Associates, Inc. (JKHY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • KUKA AG (KU2):企業の財務・戦略的SWOT分析
    KUKA AG (KU2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Chong Kun Dang Pharmaceutical Corp (185750):製薬・医療:M&Aディール及び事業提携情報
    Summary Chong Kun Dang Pharmaceutical Corp (CKD Pharma) manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients (APIs), over-the-counter (OTC) drugs, health supplements and consumer health products. Its product portfolio includes prescription products for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆